Physician profile
Robert Pepper Murray
NPI 1306987144
$76,182.72
in general payments reported to CMS, 2019-2025
4 companies · $12K in 2025
The $12K reported for 2025 was more than what 88% of Orthopaedic Surgery providers received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $15K · 2020: $6,361 · 2021: $10K · 2022: $10K · 2023: $9,695 · 2024: $13K · 2025: $12K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Royalty Or License: $34K · Food and Beverage: $35.95.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Royalty Or License | $34,123.85 |
| Food and Beverage | $35.95 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Arthrex, INC. | $76,130.96 | 2019-2025 | Arthrex |
| Boston Scientific Corporation | $19.46 | 2025 | Watchman Flx |
| Pacira Pharmaceuticals Incorporated | $16.49 | 2025 | Exparel |
| Vericel Corporation | $15.81 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Murray listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.